Search Technologies

Showing 1-2 of 2 results found

Bac-2-the-Future: An Improved System for Production of Recombinant Baculovirus

The National Cancer Institute (NCI) seeks licensing of Bac-2-the-Future, an improved system for the production of recombinant baculovirus.

Research Tools

New Insect Sf9-ET Cell Line for Determining Baculovirus Titers

The National Cancer Institute (NCI) seeks licensing partners for a novel modified insect cell line, Sf9-ET, that can quickly and efficiently determine baculovirus titers during the expression of recombinant proteins from a baculovirus-based protein expression system.

Research Tools

You are here

Product Type

Development Stage

Therapeutic Area

Institutes and Centers

Search Technologies

Bac-2-the-Future: An Improved System for Production of Recombinant Baculovirus

New Insect Sf9-ET Cell Line for Determining Baculovirus Titers